Could These Marijuana Stocks Run Today?
More publicly traded cannabis companies are starting to report earnings. This alone has been another reason shareholders have seen a slight increase in trading momentum for marijuana stocks. Speculation is high in 2024 for those who are invested in legal cannabis. Political figures from all parties are starting to find common ground with the cannabis industry.
With 2024 being an election year there is even more motivation to figure out how to pass federal reform. The amount of revenue being made has sparked the interest of many. This has also led people to invest and search for the best marijuana stocks to buy. With the sector still as volatile as ever taking up positions at good entry levels is possible.
Those who are a bit more seasoned in cannabis investing are working on different strategies to leverage the volatility. Marijuana stocks tend to be volatile due to the fear of what is unknown about the cannabis industry. But this is soon to change in the future with the passing of federal reform.
There is a large group of people who feel cannabis banking will pass before federal legalization. Regardless it is another step to ending cannabis prohibition. Historically news on cannabis reform or major issues in a positive light has resulted in better trading. Now is the time to start doing your due diligence and find the right marijuana stocks to watch.
Marijuana Stocks For Your 2024 Watchlist
- Organigram Holdings Inc. (NASDAQ:OGI)
- Neptune Wellness Solutions Inc. (NASDAQ:NEPT)
- Aurora Cannabis Inc. (NASDAQ:ACB)
Neptune Wellness Solutions Inc.
Neptune Wellness Solutions Inc. operates as a consumer packaged goods company in Canada, the United States, and internationally. In recent news, the company announced the decision of the Nasdaq hearings panel to delist common shares. 
The trading of the Company’s Common Shares on the Nasdaq will be suspended as of the opening of business on March 7, 2024. The Company is seeking to have its Common Shares quoted on the OTCQB® Venture Market of the OTCMarkets.
Organigram Holdings Inc.
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. 
In recent news, the company reported Q1 2024 earnings.
Q1 2024 Financial Highlights
- $124.6 million strategic investment from BAT
- Achieved positive Adjusted EBITDA1 and positive cash flow from operations of $7.7 million
- Improved sequential quarter-over-quarter adjusted gross margin2 from 17% in Q4 Fiscal 2023 to 31% in Q1 Fiscal 2024
- Maintained #2 market position in Canada for the last 5 consecutive months as of the end of Q1 Fiscal 20243
- Held the #1 position in milled flower, the #1 position in concentrates, the #2 position in edibles, and the #3 position in pre-rolls3
- Reintroduced Edison JOLTS to the market, achieving the #2 brand position in the capsules and ingestible extracts category in December 20233
- Launched 22 SKUs in the quarter
[Read More] 2 Top Marijuana Penny Stocks with High Momentum Before March 2024
Aurora Cannabis Inc.
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. 
On March 4th the company announced they have introduced medical cannabis pastilles for patient relief in Australia. The novel product is produced by Aurora and distributed by MedReleaf Australia.
[Read More] Cultivating Returns: The Best Cannabis REITs of March 2024
Words From The Company
“Australia is the largest nationally legal medical market globally, and as a long-standing supplier to MedReleaf Australia and recently announced parent company, we’re eager to support the continued growth and development of the market,” said Andre Jerome, Executive Vice President of Global Business Development, Aurora. “
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
